title: Construction and characterization of single-chain variable fragment antibody library derived from germline rearranged immunoglobulin variable genes.
abstract: Antibody repertoires for library construction are conventionally harvested from mRNAs of immune cells. To examine whether germline rearranged immunoglobulin (Ig) variable region genes could be used as source of antibody repertoire, an immunized phage-displayed scFv library was prepared using splenocytic genomic DNA as template. In addition, a novel frame-shifting PCR (fsPCR) step was introduced to rescue stop codon and to enhance diversity of the complementarity-determining region 3 (CDR3). The germline scFv library was initially characterized against the hapten antigen phenyloxazolone (phOx). Sequence analysis of the phOx-selective scFvs indicated that the CDRs consisted of novel as well as conserved motifs. In order to illustrate that the diversity of CDR3 was increased by the fsPCR step, a second scFv library was constructed using a single scFv clone L3G7C as a template. Despite showing similar binding characteristics towards phOx, the scFv clones that were obtained from the L3G7C-derived antibody library gave a lower non-specific binding than that of the parental L3G7C clone. To determine whether germline library represented the endogenous immune status, specific scFv clones for nucleocapsid (N) protein of SARS-associated coronavirus (SCoV) were obtained both from naïve and immunized germline scFv libraries. Both libraries yielded specific anti-N scFvs that exhibited similar binding characteristics towards recombinant N protein, except the immunized library gave a larger number of specific anti-N scFv, and clones with identical nucleotide sequences were found. In conclusion, highly diversified antibody library can be efficiently constructed using germline rearranged immunoglobulin variable genes as source of antibody repertoires and fsPCR to diversify the CDR3.
authors.affiliation: School of Biomedical Sciences, Chinese University of Hong Kong, Hong Kong, China.
authors.forename: Man
authors.initials: M
authors.lastname: Cheng
authors.forename: Shirley Y W
authors.initials: SY
authors.lastname: Chan
authors.forename: Qi
authors.initials: Q
authors.lastname: Zhao
authors.forename: Elaine Y M
authors.initials: EY
authors.lastname: Chan
authors.forename: Shannon W N
authors.initials: SW
authors.lastname: Au
authors.forename: Susanna S T
authors.initials: SS
authors.lastname: Lee
authors.forename: Wing-Tai
authors.initials: WT
authors.lastname: Cheung
mesh_terms: D000818:Animals; D004797:Enzyme-Linked Immunosorbent Assay; D007135:Immunoglobulin Variable Region / Q000235:genetics*; D051379:Mice; D008807:Mice, Inbred BALB C; D019151:Peptide Library; D016133:Polymerase Chain Reaction; D057127:Single-Chain Antibodies / Q000235:genetics*
chemical_list: D007135:Immunoglobulin Variable Region; D019151:Peptide Library; D057127:Single-Chain Antibodies
references.citation: Lancet. 2004 Jun 26;363(9427):2139-41
references.pmid: 15220038
references.citation: Nature. 1985 Aug 1-7;316(6027):412-8
references.pmid: 3927173
references.citation: Proc Natl Acad Sci U S A. 1982 Jul;79(13):4118-22
references.pmid: 6287467
references.citation: Trends Immunol. 2004 Apr;25(4):174-9
references.pmid: 15039043
references.citation: Nat Biotechnol. 1996 Mar;14(3):309-14
references.pmid: 9630891
references.citation: Br J Haematol. 1998 Mar;100(3):464-8
references.pmid: 9504627
references.citation: Biochem Pharmacol. 2006 Jan 12;71(3):319-37
references.pmid: 16336942
references.citation: Biochem Biophys Res Commun. 2005 Dec 23;338(3):1654-60
references.pmid: 16263078
references.citation: J Exp Med. 1998 Jan 5;187(1):59-70
references.pmid: 9419211
references.citation: Genome Res. 1996 Jul;6(7):633-8
references.pmid: 8796351
references.citation: Immunotechnology. 1998 Jun;4(1):1-20
references.pmid: 9661810
references.citation: Mol Immunol. 1995 May;32(7):515-21
references.pmid: 7783754
references.citation: Nature. 1989 Dec 21-28;342(6252):877-83
references.pmid: 2687698
references.citation: J Mol Recognit. 2004 Jul-Aug;17(4):332-8
references.pmid: 15227640
references.citation: Immunity. 1999 Sep;11(3):329-38
references.pmid: 10514011
references.citation: FASEB J. 2000 Mar;14(3):603-11
references.pmid: 10698976
references.citation: Proc Natl Acad Sci U S A. 1998 Sep 15;95(19):11146-51
references.pmid: 9736704
references.citation: J Biol Chem. 2010 Jun 18;285(25):19116-24
references.pmid: 20400507
references.citation: J Mol Biol. 2003 Nov 14;334(1):103-18
references.pmid: 14596803
references.citation: Nat Biotechnol. 2003 Feb;21(2):163-70
references.pmid: 12536217
references.citation: Proc Natl Acad Sci U S A. 1992 Apr 15;89(8):3576-80
references.pmid: 1565653
references.citation: J Exp Med. 2000 Jun 19;191(12):2209-20
references.pmid: 10859344
references.citation: Nature. 1991 Aug 15;352(6336):624-8
references.pmid: 1907718
references.citation: Cell. 1989 Dec 1;59(5):859-70
references.pmid: 2590942
references.citation: Nucleic Acids Res. 2005 Jan 1;33(Database issue):D671-4
references.pmid: 15608286
references.citation: Can J Microbiol. 1998 Apr;44(4):313-29
references.pmid: 9674105
references.citation: J Immunol Methods. 2004 Jul;290(1-2):29-49
references.pmid: 15261570
references.citation: J Mol Biol. 1987 Aug 20;196(4):901-17
references.pmid: 3681981
references.citation: Annu Rev Immunol. 1986;4:339-68
references.pmid: 3085692
references.citation: Science. 1993 Jan 8;259(5092):224-7
references.pmid: 7678469
references.citation: Nature. 1991 Nov 28;354(6351):308-11
references.pmid: 1956380
references.citation: Eur J Immunol. 1991 Apr;21(4):985-91
references.pmid: 2019291
references.citation: J Mol Biol. 1992 Sep 20;227(2):381-8
references.pmid: 1404359
references.citation: J Exp Med. 1978 Dec 1;148(6):1644-60
references.pmid: 722243
references.citation: Int J Cancer. 2000 Dec 15;88(6):962-9
references.pmid: 11093822
references.citation: Annu Rev Immunol. 2000;18:19-51
references.pmid: 10837051
references.citation: J Biol Chem. 1998 Aug 21;273(34):21769-76
references.pmid: 9705314
references.citation: Proc Natl Acad Sci U S A. 1998 Mar 3;95(5):2463-8
references.pmid: 9482908
references.citation: Exp Clin Immunogenet. 2001;18(4):176-98
references.pmid: 11872949
references.citation: J Mol Biol. 1999 Dec 3;294(3):701-10
references.pmid: 10610790
references.citation: Nature. 1983 Jul 28-Aug 3;304(5924):320-4
references.pmid: 6877353
references.citation: J Immunol Methods. 1999 Dec 10;231(1-2):249-60
references.pmid: 10648942
references.citation: Int Immunol. 1998 Dec;10(12):1801-5
references.pmid: 9885900
references.citation: N Biotechnol. 2010 May 31;27(2):108-17
references.pmid: 20083243
references.citation: Virology. 2003 Jan 5;305(1):77-92
references.pmid: 12504543
references.citation: Clin Cancer Res. 1999 Apr;5(4):925-31
references.pmid: 10213230
references.citation: Nature. 1984 Nov 15-21;312(5991):271-5
references.pmid: 6504141
references.citation: Science. 1987 Nov 20;238(4830):1088-94
references.pmid: 3317826
references.citation: Protein Expr Purif. 2009 Dec;68(2):190-5
references.pmid: 19683057
references.citation: Immunity. 2000 Jul;13(1):37-45
references.pmid: 10933393
references.citation: Immunol Rev. 1987 Apr;96:23-41
references.pmid: 3298007
references.citation: Proc Natl Acad Sci U S A. 2004 Feb 24;101(8):2536-41
references.pmid: 14983044
references.citation: EMBO J. 1994 Feb 1;13(3):692-8
references.pmid: 7508862